Literature DB >> 31724115

Surveillance Intensity Comparison by Risk for T1NX Locally Excised Rectal Adenocarcinoma: a Cost-Effective Analysis.

Mason McCain1, Yohanis O'Neill1,2, Hernan Hernandez3, Ryan Foley4, Brian M Sadowski1,2,3, Zachary Torgersen1,2,3, Jennifer Beaty1,2,3, Ruben Rojas Payacan5, Charles A Ternent6,7,8.   

Abstract

BACKGROUND: Controversy exists regarding the optimal surveillance strategy following local excision of T1NX rectal adenocarcinoma. This study aims to determine the cost-effectiveness of surveillance strategies for locally excised T1NX rectal adenocarcinoma based on histopathologic and local staging risk factors.
METHODS: A Markov model with 10-year follow-up was developed for cost-effectiveness analysis of high-, medium-, and low-intensity surveillance strategies after local excision of T1NX rectal adenocarcinoma. Literature review and expert consensus were utilized to populate state/transition probabilities and rewards. Based on this data, 87% of T1NX patients undergoing local excision were low risk. Healthcare utilization costs were based on Centers for Medicare and Medicaid Services data. The primary outcomes were costs in 2018 US dollars and effectiveness in life-years presented as net monetary benefit and incremental cost-effectiveness ratios. One-way sensitivity and probabilistic sensitivity analyses were performed.
RESULTS: Net monetary benefit for low-, medium-, and high-intensity surveillance strategies ($393,117.00, $397,978.80, and $397,290.00) shows medium-intensity surveillance to be optimal. One-way sensitivity analysis shows medium-intensity surveillance to be optimal when the cohort is 73-94% low risk. High-intensity surveillance is preferred when less than 73% of the cohort is low risk. Low-intensity surveillance is preferred when greater than 94% is low risk. Probabilistic sensitivity analysis of the base-case shows medium-intensity surveillance is the optimal strategy for 51.5% of the iterations performed.
CONCLUSIONS: Medium-intensity surveillance is the most cost-effective surveillance strategy for locally excised T1NX rectal adenocarcinoma in a clinically representative population model.

Entities:  

Keywords:  Cost-effectiveness; Local excision; Markov model; Rectal cancer; Rectal cancer surveillance

Mesh:

Year:  2019        PMID: 31724115     DOI: 10.1007/s11605-019-04369-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  41 in total

1.  Stage I rectal cancer: identification of high-risk patients.

Authors:  D Blumberg; P B Paty; A I Picon; J G Guillem; D S Klimstra; B D Minsky; S H Quan; A M Cohen
Journal:  J Am Coll Surg       Date:  1998-05       Impact factor: 6.113

2.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Glynne-Jones; L Wyrwicz; E Tiret; G Brown; C Rödel; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

3.  AJCC 8th Edition: Colorectal Cancer.

Authors:  Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2018-04-03       Impact factor: 5.344

4.  T1 adenocarcinoma of the rectum: transanal excision or radical surgery?

Authors:  David J Bentrem; Satoshi Okabe; W Douglas Wong; Jose G Guillem; Martin R Weiser; Larissa K Temple; Leah S Ben-Porat; Bruce D Minsky; Alfred M Cohen; Philip B Paty
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

5.  Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer.

Authors:  Pascal G Doornebosch; Floris T J Ferenschild; Johannes H W de Wilt; Imro Dawson; Geert W M Tetteroo; Eelco J R de Graaf
Journal:  Dis Colon Rectum       Date:  2010-09       Impact factor: 4.585

Review 6.  Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer.

Authors:  Scott R Steele; George J Chang; Samantha Hendren; Marty Weiser; Jennifer Irani; W Donald Buie; Janice F Rafferty
Journal:  Dis Colon Rectum       Date:  2015-08       Impact factor: 4.585

7.  Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database.

Authors:  Y Nancy You; Nancy N Baxter; Andrew Stewart; Heidi Nelson
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Long-term results of local excision for rectal cancer.

Authors:  Philip B Paty; Garrett M Nash; Paul Baron; Maureen Zakowski; Bruce D Minsky; David Blumberg; Daniel R Nathanson; Jose G Guillem; Warren E Enker; Alfred M Cohen; W Douglas Wong
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

Review 9.  When is local excision appropriate for "early" rectal cancer?

Authors:  Kotaro Maeda; Yoshikazu Koide; Hidetoshi Katsuno
Journal:  Surg Today       Date:  2013-11-21       Impact factor: 2.549

10.  Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.

Authors:  Bruno Andreoni; Antonio Chiappa; Emilio Bertani; Massimo Bellomi; Roberto Orecchia; Mariagiulia Zampino; Nicola Fazio; Marco Venturino; Franco Orsi; Angelica Sonzogni; Ugo Pace; Lorenzo Monfardini
Journal:  World J Surg Oncol       Date:  2007-07-04       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.